RACHELLE BROVELEIT: Open Payments
NPI 1588788160 · SIOUX FALLS, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$584 in 34 payments from 10 companies in 2025. Trend: 2023 $1,006 · 2024 $1,444 · 2025 $584
Food & beverage: $546Education: $39
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 16 | $244 |
| Corium, LLC | 5 | $81 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $66 |
| Neurocrine BioSciences, Inc. | 3 | $54 |
| Vanda Pharmaceuticals Inc. | 1 | $40 |
| Lundbeck LLC | 1 | $39 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Tris Pharma Inc | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| ABBVIE INC. | 1 | $14 |
Products named: REXULTI, Azstarys, CAPLYTA, INGREZZA, FANAPT, ABILIFY MAINTENA, UZEDY, Dyanavel XR.
Industry payments across SD — which companies pay providers there.
